SC, OT - I should have gotten more PYMX earlier, so my timing might not be the best on that one. But with results from 2 clinical trials coming up (probably by March/April), it may not sell off too much, though a consolidation would probably be healthy after the recent run up.
I figure it might get up to the $1.50 key resistance level prior to consolidating, or it might consolidate now. I'll try not to micromanage this one too much because the technology has such phenomenal potential. Of course if the overall market starts to fall apart, everything will likely get hit.
Btw, looks like that stock Headwaters (HW) might be just starting to break out of its ascending triangle -
Market Data 
Markets 
AI
